National Assessment Tool to Assist Member States in Implementing the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Promoting Innovation and Improving Access
(2015; 17 pages)


The World Health Organization (WHO) is working with Member States to implement the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI).

The GSPA-PHI is very broad in scope. It recommends specific actions across multiple sectors and at multiple levels (global, regional and national) to promote innovation in, and access to, essential medical technologies in low- and middle-income countries. While the WHO is working to implement the GSPA-PHI at all levels, the most important effort must be at the national level.

The strategy is based on specific actions that several stakeholders, mainly WHO and countries, should implement in various areas to ensure that capacity is developed to generate innovation in medical technologies, sufficient research is conducted to address needs of developing countries in terms of medical technologies and access to new, needed technologies is promoted in these countries.

As part of its efforts to implement the GSPA-PHI, the WHO has developed a National Assessment Tool (NAT) based on country-specific action items in the strategy. This tool facilitates a systematic assessment of the conducive environment to innovation for medical technologies, helping Member States to analyse their situation in terms of policies, regulations, legislations, infrastructure and funding.

El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019